Research & Development



  當雲瑯提出一個粗糙的想法之後,劉徹麾下的能人異士總有辦法將他進化成完美的模樣。   大長秋嗤的冷笑一聲道︰“我沒有求你保護來氏,只求你保護一個女子……來氏死絕也不算大事,那個女子卻自戕身亡,聶長謀你何以教我?”人人日青青草在线视频   郭解見武陽一臉的迷茫之色,就嘆口氣道︰“當初我以為自己乃是一方豪雄,雖然是白身,在鄉間也是一言九鼎的豪邁人物。天天射   于是,長門宮覺得自己應該參加進來,于是,大長秋就帶著長門宮產業名錄來找雲瑯。   “不會,他們只會從雲氏貸款,然後再以一成二的利息放出去。”天天好逼网   “詐尸了。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo